(Left to right): Associate Professor Angela Todd, Associate Professor Anthony Delaney, Associate Professor Alexander Guminski, Professor Bruce Robinson, Associate Professor Sarah Glastras, Professor David Hunter
Celebrating our clinical trials teams and their life- changing impact
International Clinical Trials day provided the perfect opportunity to celebrate the scope of clinical trials across NSLHD. More than a hundred people attended an event including members of our trial workforce, researchers, Director of Research Professor Bruce Robinson and Interim CE Lee Gregory. Lee said we have a strong clinical trial culture across the district, with close to 300 trials currently underway, involving more than a thousand staff. “This is a significant achievement which has helped to position the district as a leader in research and innovation,” he said. “Each trial is broadening our understanding, influencing policy, and contributing to new models of evidenced-based care. “We are in the fortunate position that we’re able to efficiently translate the latest research progress into clinical practice, and this is directly improving health outcomes and wellbeing. “I would like to acknowledge the remarkable impact of our clinical trials workforce.” Professor Robinson said the event provided the chance to recognise local and international clinical trials, and the contribution of patients and the trial workforce.
“Never lose sight of the value of clinical trials, the important benefits to the community and the broad access to new treatments and devices,” he said. “It is entirely possible that an investigator-led trial developed here could become a game- changer and alter global clinical practice.” Associate Professor Anthony Delaney from the RNSH Intensive Care Unit addressed the event, saying that trials undertaken during the COVID pandemic had demonstrated that you could produce significant results in a short space of time. “Our experience showed that an efficiently run trial, which was time and cost effective, could deliver tangible improvements to healthcare. “A good example of that was a large scale trial during Covid which showed that steroids were effective in saving lives, but hydroxychloroquine and antiviral medications were not effective. “By incorporating this evidence-based information, we were able to quickly improve patient outcomes, which was a wonderful result.” To mark the event, clinical trial teams also co-ordinated a dynamic display at RNSH to showcase a range of clinical trials and increase community engagement.
WWW.NSLHD.HEALTH.NSW.GOV.AU
3
Made with FlippingBook - professional solution for displaying marketing and sales documents online